table of content
1 Study Coverage
1.1 Anticancer Drugs Product Introduction
1.2 Global Anticancer Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Anticancer Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Anticancer Drugs Sales in Volume for the Year 2017-2028
1.3 United States Anticancer Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Anticancer Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Anticancer Drugs Sales in Volume for the Year 2017-2028
1.4 Anticancer Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Anticancer Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Anticancer Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Anticancer Drugs Market Dynamics
1.5.1 Anticancer Drugs Industry Trends
1.5.2 Anticancer Drugs Market Drivers
1.5.3 Anticancer Drugs Market Challenges
1.5.4 Anticancer Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Anticancer Drugs Market Segment by Type
2.1.1 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
2.1.2 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
2.1.3 Hormonal Drugs
2.2 Global Anticancer Drugs Market Size by Type
2.2.1 Global Anticancer Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Anticancer Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Anticancer Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Anticancer Drugs Market Size by Type
2.3.1 United States Anticancer Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Anticancer Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Anticancer Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Anticancer Drugs Market Segment by Application
3.1.1 Lung Cancer
3.1.2 Breast Cancer
3.1.3 Leukemia
3.1.4 Colorectal Cancer
3.1.5 Other
3.2 Global Anticancer Drugs Market Size by Application
3.2.1 Global Anticancer Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Anticancer Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Anticancer Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Anticancer Drugs Market Size by Application
3.3.1 United States Anticancer Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Anticancer Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Anticancer Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Anticancer Drugs Competitor Landscape by Company
4.1 Global Anticancer Drugs Market Size by Company
4.1.1 Top Global Anticancer Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Anticancer Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Anticancer Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Anticancer Drugs Price by Manufacturer (2017-2022)
4.2 Global Anticancer Drugs Concentration Ratio (CR)
4.2.1 Anticancer Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Anticancer Drugs in 2021
4.2.3 Global Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Anticancer Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Anticancer Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Anticancer Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Anticancer Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Anticancer Drugs Market Size by Company
4.5.1 Top Anticancer Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Anticancer Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Anticancer Drugs Sales by Players (2020, 2021 & 2022)
5 Global Anticancer Drugs Market Size by Region
5.1 Global Anticancer Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Anticancer Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Anticancer Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Anticancer Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Anticancer Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Anticancer Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Anticancer Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Anticancer Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Anticancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Anticancer Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Anticancer Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Anticancer Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Anticancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Anticancer Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Anticancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Anticancer Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Anticancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 F. Hoffmann-La Roche Ltd
7.1.1 F. Hoffmann-La Roche Ltd Corporation Information
7.1.2 F. Hoffmann-La Roche Ltd Description and Business Overview
7.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 F. Hoffmann-La Roche Ltd Anticancer Drugs Products Offered
7.1.5 F. Hoffmann-La Roche Ltd Recent Development
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Corporation Information
7.2.2 Eli Lilly and Company Description and Business Overview
7.2.3 Eli Lilly and Company Anticancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Eli Lilly and Company Anticancer Drugs Products Offered
7.2.5 Eli Lilly and Company Recent Development
7.3 CELGENE CORPORATION
7.3.1 CELGENE CORPORATION Corporation Information
7.3.2 CELGENE CORPORATION Description and Business Overview
7.3.3 CELGENE CORPORATION Anticancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 CELGENE CORPORATION Anticancer Drugs Products Offered
7.3.5 CELGENE CORPORATION Recent Development
7.4 Novartis AG
7.4.1 Novartis AG Corporation Information
7.4.2 Novartis AG Description and Business Overview
7.4.3 Novartis AG Anticancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Novartis AG Anticancer Drugs Products Offered
7.4.5 Novartis AG Recent Development
7.5 Pfizer Inc
7.5.1 Pfizer Inc Corporation Information
7.5.2 Pfizer Inc Description and Business Overview
7.5.3 Pfizer Inc Anticancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Pfizer Inc Anticancer Drugs Products Offered
7.5.5 Pfizer Inc Recent Development
7.6 Amgen Inc
7.6.1 Amgen Inc Corporation Information
7.6.2 Amgen Inc Description and Business Overview
7.6.3 Amgen Inc Anticancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Amgen Inc Anticancer Drugs Products Offered
7.6.5 Amgen Inc Recent Development
7.7 Bayer AG
7.7.1 Bayer AG Corporation Information
7.7.2 Bayer AG Description and Business Overview
7.7.3 Bayer AG Anticancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Bayer AG Anticancer Drugs Products Offered
7.7.5 Bayer AG Recent Development
7.8 AstraZeneca
7.8.1 AstraZeneca Corporation Information
7.8.2 AstraZeneca Description and Business Overview
7.8.3 AstraZeneca Anticancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 AstraZeneca Anticancer Drugs Products Offered
7.8.5 AstraZeneca Recent Development
7.9 Takeda Pharmaceutical Company Limited
7.9.1 Takeda Pharmaceutical Company Limited Corporation Information
7.9.2 Takeda Pharmaceutical Company Limited Description and Business Overview
7.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Takeda Pharmaceutical Company Limited Anticancer Drugs Products Offered
7.9.5 Takeda Pharmaceutical Company Limited Recent Development
7.10 Merck & Co.
7.10.1 Merck & Co. Corporation Information
7.10.2 Merck & Co. Description and Business Overview
7.10.3 Merck & Co. Anticancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Merck & Co. Anticancer Drugs Products Offered
7.10.5 Merck & Co. Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Anticancer Drugs Industry Chain Analysis
8.2 Anticancer Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Anticancer Drugs Distributors
8.3 Anticancer Drugs Production Mode & Process
8.4 Anticancer Drugs Sales and Marketing
8.4.1 Anticancer Drugs Sales Channels
8.4.2 Anticancer Drugs Distributors
8.5 Anticancer Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
